Cart
sales@molnova.com
FLTX1
CAS No. 1481401-71-1
FLTX1 ( —— )
Catalog No. M23635 CAS No. 1481401-71-1
FLTX1, a fluorescent Tamoxifen derivative that can specifically label intracellular Tamoxifen-binding sites (estrogen receptors) under permeabilized and non-permeabilized conditions.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 237 | In Stock |
|
| 10MG | 372 | In Stock |
|
| 25MG | 623 | In Stock |
|
| 50MG | 887 | In Stock |
|
| 100MG | 1197 | In Stock |
|
| 500MG | 2394 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFLTX1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFLTX1, a fluorescent Tamoxifen derivative that can specifically label intracellular Tamoxifen-binding sites (estrogen receptors) under permeabilized and non-permeabilized conditions.?
-
DescriptionFLTX1, a fluorescent Tamoxifen derivative that can specifically label intracellular Tamoxifen-binding sites (estrogen receptors) under permeabilized and non-permeabilized conditions.?FLTX1 exhibits the potent antiestrogenic properties of Tamoxifen in breast cancer cells.?FLTX1 is devoid of the estrogenic agonistic effect on the uterus.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorERα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1481401-71-1
-
Formula Weight520.6
-
Molecular FormulaC31H28N4O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C3=CC=C(C4=NON=C34)[N+](=O)[O-])C5=CC=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(E/Z)-GSK5182
(E/Z)-GSK5182 is a racemic compound of (E)-GSK5182 and (Z)-GSK5182 isomers.
-
27-Hydroxycholestero...
27-Hydroxycholesterol is a selective modulator of estrogen receptor and an agonist of the liver X receptor.
-
(Z)-4-Hydroxytamoxif...
A major metabolite of tamoxifen, a well-known Estrogen receptor antagonist in breast but partial estrogen receptor agonist in endometrium.
